Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
14,534 total articles
Shares of Greenland Energy Company (NASDAQ:GLND) climbed 20% after the company disclosed a contract with Halliburton to provide integrated consulting services, logistics management and comprehensive well and drilling support for its 2026 Jameson Land onshore campaign. The deal complements earlier partnerships with Stampede Drilling and Desgagnés as…
Critical Metals Corp. plans to acquire all outstanding shares of European Lithium Ltd. through a stock-for-stock transaction that values the deal at approximately $835 million based on Critical Metals’ April 22, 2026 closing price. The announcement sent Critical Metals shares up 7.5% and would give Critical Metals full ownership of the Tanbreez Rar…
Customers Bank has signed a multiyear partnership with OpenAI to automate lending workflows and customer onboarding. The arrangement will embed OpenAI engineers at the bank, with management targeting an efficiency ratio improvement from about 49% to the low 40s and expecting increased returns beginning in 2027. The deal also includes joint developm…
Compass Therapeutics (CMPX) shares plunged 80% after mixed outcomes from its Phase II/III COMPANION-002 trial testing tovecimig plus paclitaxel in second-line biliary tract cancer. The study met the key secondary endpoint of progression-free survival with high statistical significance, but failed to reach overall survival secondary endpoints, a res…
Terns Pharmaceuticals said on Monday that the U.S. Food and Drug Administration has awarded Breakthrough Therapy Designation to its oral allosteric BCR::ABL1 inhibitor, TERN-701, for adults with chronic phase chronic myeloid leukemia without the T315I mutation who have previously received two or more tyrosine kinase inhibitors. The decision was bas…
AbbVie has submitted a request to the U.S. Food and Drug Administration to approve a subcutaneous induction regimen of SKYRIZI (risankizumab-rzaa) for adults with moderately to severely active Crohn’s disease. The filing is supported by results from the Phase 3 AFFIRM trial involving 289 patients and, if approved, would allow patients to choose bet…
HawkEye 360 initiated an initial public offering roadshow on April 27, proposing 16 million common shares priced between $24.00 and $26.00 each. With a 30-day overallotment option for an additional 2.4 million shares, the deal could generate about $416 million at the top of the range if that option is fully exercised. The company aims to list on th…
HawkEye 360 launched the roadshow for its initial public offering, proposing to sell 16 million shares priced between $24.00 and $26.00 each and naming an overallotment option that could lift proceeds to about $416 million. The company has filed a registration statement with the Securities and Exchange Commission that has not yet become effective, …
Compass Therapeutics stock dropped 80% after the company released data from its COMPANION-002 Phase 2/3 trial of tovecimig in biliary tract cancer. The combination of tovecimig and paclitaxel improved progression-free survival and response rate but did not achieve statistical significance for overall survival, with the analysis confounded by substa…
A rapid rise in jet fuel prices, which have climbed from roughly $85-$90 per barrel to a range of $150-$200 per barrel amid the U.S.-Israeli war on Iran, has forced airlines across the globe to take a range of measures. Carriers are raising ticket prices and fuel surcharges, cutting capacity on select routes, suspending or withdrawing earnings guid…
Futures tied to Canada’s principal equity gauge moved lower Monday as investors prepared for a week loaded with quarterly earnings, central bank guidance and persistent geopolitical tensions between the U.S. and Iran that have disrupted crude flows through the Strait of Hormuz. U.S. contracts were mixed, oil prices rose and gold remained subdued ah…
Qualcomm stock jumped sharply in premarket trade after an analyst posted that OpenAI is collaborating with the chipmaker and Taiwan’s MediaTek to build smartphone processors for an AI-first device. The report names Luxshare as the exclusive system design and manufacturing partner and projects mass production as likely in 2028. The companies named i…
U.S. equity benchmarks climbed to record levels as hopes of renewed nuclear talks between Iran and the United States softened risk perceptions, while investors brace for a dense slate of mega-cap earnings and a Federal Reserve decision that could reshape rate expectations. Energy-market developments and forthcoming macro releases add further uncert…
Joby Aviation's stock rose after the company completed New York City's first point-to-point electric vertical takeoff and landing demonstration flights, connecting Manhattan heliports and John F. Kennedy International Airport in under 10 minutes. The flights form part of a federal eVTOL Integration Pilot Program and build on Joby's acquisition of B…
Peloton Interactive's stock rose about 6% after Spotify announced a partnership that gives Premium users in supported markets access to more than 1,400 ad-free Peloton on-demand classes. The move places Peloton content inside Spotify's expanding fitness offering and enables Premium users to stream and download a wide range of workouts across device…
Samsung Electronics is planning to halt sales of televisions and home appliances in China before year-end, with a final decision possibly coming as soon as the end of April. The company would maintain local production of refrigerators, washing machines and air conditioners in China to serve as manufacturing hubs for overseas shipments. Declining pr…
Nitto Denko reported operating profit of ¥183.6 billion for the fiscal year ended March 2026, a 1% decline from the prior year and marginally under the company forecast. Management cited roughly ¥1.5 billion of special-factor charges. For the year ending March 2027 the firm projects operating profit of ¥193 billion, a 5% increase year-over-year, an…
Mizuho analyst Gregg Moskowitz moved in opposite directions on two major software names, upgrading CrowdStrike to Outperform with a higher price target and downgrading Adobe to Neutral while cutting its target. The decisions reflect contrasting views on each company's ability to leverage AI initiatives and current valuation dynamics.
Medtronic reported that a cyber intrusion last week targeted the network that supports its corporate IT systems. The company said the incident did not affect its medical products, patient safety, manufacturing or distribution, and it does not expect a material impact to its business or financial results. Medtronic has activated its response plans a…
U.S. stock futures showed mixed action Monday morning as traders readied for a congested week of events ranging from geopolitical developments to earnings from large AI-focused cloud providers. By 06:46 ET (10:46 GMT), Dow futures were down 39 points (-0.1%), the S&P 500 was essentially flat, and Nasdaq 100 futures were up 37 points (0.1%). Several…
Medtronic reported that a cyber incident that struck parts of its corporate IT infrastructure last week did not affect its medical devices, patient safety, manufacturing or distribution operations. The company has engaged cybersecurity specialists, activated response plans and does not expect the attack to materially alter its business or financial…
Suja Life, Inc. has begun its initial public offering roadshow after filing a registration statement with the SEC. The company is offering 8,888,889 shares of Class A common stock, with an expected price range of $21.00 to $24.00 per share. Suja Life and a selling stockholder have granted underwriters options to purchase additional shares. Proceeds…
Sagimet Biosciences reported a 30% jump in its stock after announcing plans to begin a U.S. Phase 3 trial of denifanstat in moderate to severe acne in the second half of 2026, contingent on IND clearance. The company also disclosed favourable Phase 3 topline results from its China program, prioritized dermatology in capital allocation, is seeking n…
HawkEye 360 filed papers in the United States indicating it aims to raise as much as $416 million through an initial public offering, pricing 16 million shares between $24 and $26. The filing implies a company valuation of up to $2.42 billion. The Herndon, Virginia firm plans to list on the New York Stock Exchange under the symbol HAWK, with severa…
Bank of America strategists Paul Ciana and Jonathan Hartley caution that the common 'sell in May and go away' rule misses important intra-season patterns. Their analysis of S&P 500 returns since 1928 shows the May-October six-month stretch underperforms November-April on average, but the shortfall is concentrated in August-October. BofA argues inve…
